Elizabeth Holmes Challenges U.S. Charges Over Theranos Blood Tests
- Founder, ex-president of blood-test startup face August trial
- Judge zeroes in on alleged misrepresentations to consumers
This article is for subscribers only.
Theranos Inc. founder Elizabeth Holmes mounted an attack Monday against charges that she defrauded patients who used her company’s blood tests.
The former chief executive of the blood-test startup that imploded after reaching a $9 billion valuation argues that allegations she misled patients should be dismissed as too vague and because the government can’t prove that people who got inaccurate test results were actually harmed.